Beijing Beilu Pharmaceutical Co (SZSE:300016) Other Long-Term Liabilities : ¥96 Mil (As of Mar. 2025)

View and export this data going back to 2010. Start your Free Trial

What is Beijing Beilu Pharmaceutical Co Other Long-Term Liabilities?

Beijing Beilu Pharmaceutical Co's other long-term liabilities for the quarter that ended in Mar. 2025 was ¥96 Mil.

Beijing Beilu Pharmaceutical Co's quarterly other long-term liabilities increased from Sep. 2024 (¥78 Mil) to Dec. 2024 (¥88 Mil) and increased from Dec. 2024 (¥88 Mil) to Mar. 2025 (¥96 Mil).

Beijing Beilu Pharmaceutical Co's annual other long-term liabilities increased from Dec. 2022 (¥66 Mil) to Dec. 2023 (¥74 Mil) and increased from Dec. 2023 (¥74 Mil) to Dec. 2024 (¥88 Mil).

Beijing Beilu Pharmaceutical Co Other Long-Term Liabilities Historical Data

The historical data trend for Beijing Beilu Pharmaceutical Co's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beijing Beilu Pharmaceutical Co Other Long-Term Liabilities Chart

Beijing Beilu Pharmaceutical Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Other Long-Term Liabilities

Get a 7-Day Free Trial

58.78

56.43

66.45

74.22

87.78

Beijing Beilu Pharmaceutical Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Other Long-Term Liabilities	Get a 7-Day Free Trial															72.88	80.96	78.03	87.78	95.58

Beijing Beilu Pharmaceutical Co Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

Beijing Beilu Pharmaceutical Co Other Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of Beijing Beilu Pharmaceutical Co's Other Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Beijing Beilu Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Beijing Beilu Pharmaceutical Co Ltd (SZSE:300016) » Definitions » Other Long-Term Liabilities

Traded in Other Exchanges

N/A

Address

No. 3, Shuiyuan West Road, Miyun District, Beijing, CHN, 100082

Website

http://www.beilu.com.cn

Beijing Beilu Pharmaceutical Co Ltd is engaged in the research and development, production, and sales of pharmaceutical products. The products of the company are contrasted agent series, psychotropic, and hypoglycemic products which include iopamidol injection, iodixanol injection, and reglinide tablets.

Executives

Zong Li	Directors, executives
Hong Cheng Jie	Director
Duan Xian Zhu	Directors, executives
Zhu Zhi	Director
Wang Dai Xue	Director
Li Hong	Directors, executives
Liu Ning	Directors, executives
Wu Rui Hua	Directors, executives
Wu Jie	Executives
Liu Dong Long	Supervisors
Hong Wei	Directors, executives

Beijing Beilu Pharmaceutical Co Headlines

No Headlines